Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71:09–249.
Sampson N, Neuwirt H, Puhr M, Klocker H, Eder IE. In vitro model systems to study androgen receptor signaling in prostate cancer. Endocr Relat Cancer. 2013;20:R49–64.
Article CAS PubMed Google Scholar
Wu X, Gong S, Roy-Burman P, Lee P, Culig Z. Current mouse and cell models in prostate cancer research. Endocr Relat Cancer. 2013;20:R155–70. https://doi.org/10.1530/ERC-1512-0285.
Article CAS PubMed Google Scholar
Cunningham D, You Z. In vitro and in vivo model systems used in prostate cancer research. J Biol methods. 2015;2:e17.
Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, et al. The LNCaP cell line–a new model for studies on human prostatic carcinoma. Prog Clin Biol Res. 1980;37:115–32.
Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investig Urol. 1979;17:16–23.
Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer. 1978;21:274–81.
Article CAS PubMed Google Scholar
Webber MM, Bello D, Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines. Prostate. 1996;29:386–94.
Article CAS PubMed Google Scholar
Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. Vitr Cell Developmental Biol Anim. 1995;31:14–24.
Sobel RE, Sadar MD. Cell lines used in prostate cancer research: A compendium of old and new cell lines - Part 2. J Urol. 2005;173:360–72.
Article CAS PubMed Google Scholar
Sobel RE, Sadar MD. Cell lines used in prostate cancer research: A compendium of old and new cell lines - Part 1. J Urol. 2005;173:342–59.
Article CAS PubMed Google Scholar
Namekawa T, Ikeda K, Horie-Inoue K, Inoue S. Application of prostate cancer models for preclinical study: Advantages and limitations of cell lines, patient-derived xenografts, and three-dimensional culture of patient-derived cells. Cells. 2019;8:74.
Article CAS PubMed PubMed Central Google Scholar
Frame FM, Noble AR, O’Toole P, Marrison J, Godden T, O’Brien A, et al. Assessing the advantages, limitations and potential of human primary prostate epithelial cells as a pre-clinical model for prostate cancer research. Adv Exp Med Biol. 2019;1164:109–18.
Article CAS PubMed Google Scholar
Saranyutanon S, Deshmukh SK, Dasgupta S, Pai S, Singh S, Singh AP. Cellular and molecular progression of prostate cancer: Models for basic and preclinical research. Cancers (Basel). 2020;12:2651.
Article CAS PubMed Google Scholar
Kogan I, Goldfinger N, Milyavsky M, Cohen M, Shats I, Dobler G, et al. hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis. Cancer Res. 2006;66:3531–40.
Article CAS PubMed Google Scholar
Webber MM, Bello D, Kleinman HK, Wartinger DD, Williams DE, Rhim JS. Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. Carcinogenesis. 1996;17:1641–6.
Article CAS PubMed Google Scholar
Ke X-S, Qu Y, Goldfinger N, Rostad K, Hovland R, Akslen LA, et al. Epithelial to mesenchymal transition of a primary prostate cell line with switches of cell adhesion modules but without malignant transformation. PLOS ONE. 2008;3:e3368.
Article PubMed PubMed Central Google Scholar
Choo CK, Ling MT, Chan KW, Tsao SW, Zheng Z, Zhang D, et al. Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames. Prostate. 1999;40:150–8.
Article CAS PubMed Google Scholar
Lai J, An J, Nelson CC, Lehman ML, Batra J, Clements JA. Analysis of androgen and anti-androgen regulation of KLK-related peptidase 2, 3, and 4 alternative transcripts in prostate cancer. Biol Chem. 2014;395:1127–32.
Article CAS PubMed Google Scholar
Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res. 2002;12:996–1006.
Article CAS PubMed PubMed Central Google Scholar
Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:R36.
Article PubMed PubMed Central Google Scholar
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–9.
Article PubMed PubMed Central Google Scholar
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–9.
Article PubMed PubMed Central Google Scholar
Liao Y, Smyth GK, Shi W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–30.
Article CAS PubMed Google Scholar
Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11:R25.
Article PubMed PubMed Central Google Scholar
Robinson MD, McCarthy DJ, Smyth GK. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–40.
Article CAS PubMed Google Scholar
Feng J, Meyer CA, Wang Q, Liu JS, Shirley Liu X, Zhang Y. GFOLD: A generalized fold change for ranking differentially expressed genes from RNA-seq data. Bioinformatics. 2012;28:2782–8.
Article CAS PubMed Google Scholar
Cagle P, Niture S, Srivastava A, Ramalinga M, Aqeel R, Rios-Colon L, et al. MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells. Sci Rep. 2019;9:9776.
Article PubMed PubMed Central Google Scholar
Li H, Kim C, Liu W, Zhu J, Chin K, Rodriguez-Canales J, et al. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer. Int J Cancer. 2020;146:1346–58.
Article CAS PubMed Google Scholar
Kanehisa M, Sato Y, Furumichi M, Morishima K, Tanabe M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 2019;47:D590–95.
Article CAS PubMed Google Scholar
Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.
Article CAS PubMed PubMed Central Google Scholar
Carm KT, Hoff AM, Bakken AC, Axcrona U, Axcrona K, Lothe RA, et al. Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer. Sci Rep. 2019;9:13579.
Article PubMed PubMed Central Google Scholar
Ceder JA, Aalders TW, Schalken JA. Label retention and stem cell marker expression in the developing and adult prostate identifies basal and luminal epithelial stem cell subpopulations. Stem Cell Res Ther. 2017;8:95.
Article PubMed PubMed Central Google Scholar
Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis. 1997;18:1215–23.
Article CAS PubMed Google Scholar
Devlies W, Handle F, Devos G, Joniau S, Claessens F. Preclinical models in prostate cancer: Resistance to AR targeting therapies in prostate cancer. Cancers (Basel). 2021;13:915.
Article CAS PubMed Google Scholar
Elbadawy M, Abugomaa A, Yamawaki H, Usui T, Sasaki K. Development of prostate cancer organoid culture models in basic medicine and translational research. Cancers (Basel). 2020;12:777.
Article CAS PubMed Google Scholar
Theodore S, Sharp S, Zhou J, Turner T, Li H, Miki J, et al. Establishment and characterization of a pair of non-malignant and malignant tumor derived cell lines from an African American prostate cancer patient. Int J Oncol. 2010;37:1477–82.
留言 (0)